Prudential Financial
HSTO

Prudential Financial’s Histogen Inc. Common Stock HSTO Stock Holding History

Prudential Financial’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,400
Closed -$26K – 2762
2022
Q3 		$26K Buy
19,400
+6,400
+49% +$14.4K ﹤0.01% 2619
2022
Q2 		$30K Buy
+13,000
New +$46.7K ﹤0.01% 2620

Other funds holding HSTO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prudential Financial's HSTO Position: Q4 2022 in Review

Prudential Financial sold out of Histogen Inc. Common Stock (HSTO) in Q4 2022, closing a stake of 19,400 shares — an estimated $26K sold.

Prudential Financial first reported a position in HSTO in Q2 2022 and held it in 2 quarters. The position peaked at $30K in Q2 2022. 13 funds tracked by Wall St. Rank hold HSTO as of Q4 2022.

  • Prudential Financial reported no remaining Histogen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Prudential Financial sold 19,400 Histogen Inc. Common Stock shares in Q4 2022, an estimated $26K.
  • Prudential Financial first reported a position in Histogen Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Prudential Financial's Histogen Inc. Common Stock position peaked at $30K in Q2 2022.
  • 13 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2022.

Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.